Table 1.
Patient demographics (n = 36)
| Characteristics | Median (range) or no. of patients |
|---|---|
| Age, y | 69 (55-85) |
| iPSA | 9.0 (4.3-130) |
| AJCC T stage | |
| T1c to T2a | 12 |
| T2b to T2c | 12 |
| T3a | 7 |
| T3b | 5 |
| ISUP 2017 grade | |
| 2 | 9 |
| 3 | 12 |
| 4 | 5 |
| 5 | 10 |
| Risk group | |
| Intermediate | 13 |
| High | 23 |
| ADT use | 22 |
| Image guidance | |
| Calypso | 11 |
| Kim gating | 23 |
| TrueBeam gating | 3 |
| Dose levels | |
| 1 | 9 |
| 2 | 6 |
| 3 | 21 |
Abbreviations: ADT = Androgen deprivation therapy; AJCC = American Joint Committee on Cancer; iPSA = initial PSA; ISUP = International Society of Urological Pathology.